Business
Press Release Dec 19 2022
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 19, 2022, titled "Glenmark Pharmaceuticals receives ANDA approval for Nicardipine HydrochlorideCapsules, 20 mg and 30 mg".
About this update from Glenmark Pharmaceuticals Limited
[{"type":"text","content":" Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 19, 2022, titled \"Glenmark Pharmaceuticals receives ANDA approval for Nicardipine HydrochlorideCapsules, 20 mg and 30 mg\". View Attachment","length":374,"tagName":"div"}]